Clinical Trials Arena on MSN
Keenova seeks Xiaflex expansion on late-stage rare disease win
If approved, Xiaflex would become the first FDA-approved therapy to reach patients with plantar fibromatosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results